« Back
Home /
Altiratinib(DCC-2701)

Altiratinib(DCC-2701)

Item no.	DCC-DC8072-100mg
Manufacturer	DCChemicals
CASRN	1345847-93-9
Amount	100 mg
Quantity options	100 mg 1 g 250 mg
Category	Reagents & Chemicals Molecules
Type	Inhibitors
Applications	other
Specific against	other
Purity	>98%
Smiles	FC1=C([H])C(=C(C([H])=C1N([H])C(C1(C(N([H])C2C([H])=C([H])C(=C([H])C=2[H])F)=O)C([H])([H])C1([H])[H])=O)F)OC1C([H])=C([H])N=C(C=1[H])N([H])C(C1([H])C([H])([H])C1([H])[H])=O
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	Altiratinib,DCC2701,DCC 2701
Similar products	1345847-93-9
Available
Manufacturer - Applications	Altiratinib is a MET/TIE2/VEGFR2/TRK (A, B, C) kinase inhibitor in Phase 1 clinical development for the treatment of invasive solid tumors including glioblastoma.
Storage Conditions	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Molecular Weight	510, 4646
Note	For research and scientific purpose only, not for human use.
Chemical name	N-(4-((2-(cyclopropanecarboxamido)pyridin-4-yl)oxy)-2, 5-difluorophenyl)-N-(4-fluorophenyl)cyclopropane-1, 1-dicarboxamide.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100 mg

available

Delivery expected until 1/1/2026

Express Delivery: Save 6 days

Compare

Add to wishlist

Get an offer